Skip to main content
Top
Published in: Lasers in Medical Science 3/2014

01-05-2014 | Brief Report

The 532-nm 180-W (GreenLight®) laser vaporization of the prostate for the treatment of lower urinary tract symptoms: how durable is the new side-fire fiber with integrated cooling system?

Authors: Claus Brunken, Maximilian Munsch, Stephan Tauber, Rainer Schmidt, Christian Seitz

Published in: Lasers in Medical Science | Issue 3/2014

Login to get access

Abstract

The 532-nm side-fire laser vaporization is established for the treatment of symptomatic benign prostate hyperplasia. Meanwhile, the third generation of this system is offered by American Medical Systems, Inc. The laser power increased from 80 and 120 to 180 W from the first to the third generation. Despite good functional results, with the 80- and 120-W systems, the removal of prostate tissue is limited because of fiber degradation. To overcome this problem, the fiber was designed newly with an integrated cooling system and a sensor for decreasing the laser energy in case of overheating. We evaluate whether the new fiber still suffers from degradation with consecutive drop of power transmission during the procedure. The power output of the cooled fiber was measured in vitro and during prostate vaporization in ten patients. Laser beam power was measured at baseline and after the application each of 50 kJ during laser vaporization. Power emission of the fiber remains constant at 20, 80, and 180 W of power settings over the whole 40-kJ lifespan. During the transurethral procedure, a median total energy of 276 kJ (standard deviation 153 kJ) was applied for vaporization. Median power output from the fiber at the end of the procedure was 97 % from the baseline value. There were no fiber malfunctions observed. In contrast to former generations, the third-generation laser fiber is durable without significant power loss during prostate vaporization.
Literature
1.
go back to reference Capitán C, Blázquez C, Martin MD et al (2011) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol 60:734–739PubMedCrossRef Capitán C, Blázquez C, Martin MD et al (2011) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol 60:734–739PubMedCrossRef
2.
go back to reference Al-Ansari A, Younes N, Samping VP et al (2010) GreenLight HPS 120 W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow up. Eur Urol 58:349–355PubMedCrossRef Al-Ansari A, Younes N, Samping VP et al (2010) GreenLight HPS 120 W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow up. Eur Urol 58:349–355PubMedCrossRef
3.
go back to reference Pereira-Correia JA, de Moraes Sousa KD, Santos JB et al (2012) GreenLight HPS 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int 110:1184–1189PubMedCrossRef Pereira-Correia JA, de Moraes Sousa KD, Santos JB et al (2012) GreenLight HPS 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int 110:1184–1189PubMedCrossRef
4.
go back to reference Seki N, Nomura H, Yamaguchi A et al (2008) Evaluation of the learning curve for photoselective vaporization of the prostate over the course of 74 cases. J Endourol 22:1731–1735PubMedCrossRef Seki N, Nomura H, Yamaguchi A et al (2008) Evaluation of the learning curve for photoselective vaporization of the prostate over the course of 74 cases. J Endourol 22:1731–1735PubMedCrossRef
5.
go back to reference Ahyai S, Gilling P, Kaplan S et al (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58:384–397PubMedCrossRef Ahyai S, Gilling P, Kaplan S et al (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58:384–397PubMedCrossRef
6.
go back to reference Ruszat R, Seitz M, Wyler SF et al (2008) GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 54:893–901PubMedCrossRef Ruszat R, Seitz M, Wyler SF et al (2008) GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 54:893–901PubMedCrossRef
7.
go back to reference Brunken C, Seitz C, Tauber S, Schmidt R (2011) Transurethral GreenLight laser enucleation of the prostate—a feasibility study. J Endourol 25:1199–1201PubMedCrossRef Brunken C, Seitz C, Tauber S, Schmidt R (2011) Transurethral GreenLight laser enucleation of the prostate—a feasibility study. J Endourol 25:1199–1201PubMedCrossRef
8.
go back to reference Malek R, Kang HW, Peng YS et al (2011) Photoselective vaporization prostatectomy: experience with a novel 180 W 532 nm lithium triborate laser and fiber delivery system in living dogs. J Urol 185:712–718PubMedCrossRef Malek R, Kang HW, Peng YS et al (2011) Photoselective vaporization prostatectomy: experience with a novel 180 W 532 nm lithium triborate laser and fiber delivery system in living dogs. J Urol 185:712–718PubMedCrossRef
9.
go back to reference Te AE (2006) The next generation in laser treatments and the role of the GreenLight high performance system laser. Rev Urol suppl 8:S24–S30 Te AE (2006) The next generation in laser treatments and the role of the GreenLight high performance system laser. Rev Urol suppl 8:S24–S30
10.
go back to reference Schwartz J, Renard J, Wolf JP et al (2010) High-power potassium-titanyl-phosphate laser fibres for endovaporization of benign prostatic hyperplasia: how much do they deteriorate during the procedure? BJU Int 107:1938–1942PubMedCrossRef Schwartz J, Renard J, Wolf JP et al (2010) High-power potassium-titanyl-phosphate laser fibres for endovaporization of benign prostatic hyperplasia: how much do they deteriorate during the procedure? BJU Int 107:1938–1942PubMedCrossRef
11.
go back to reference Hermanns T, Sulser T, Fatzer M et al (2009) Laser fibre deterioration and loss of power output during photoselective 80-w potassium-titanyl-phosphate laser vaporization of the prostate. Eur Urol 55:679–685PubMedCrossRef Hermanns T, Sulser T, Fatzer M et al (2009) Laser fibre deterioration and loss of power output during photoselective 80-w potassium-titanyl-phosphate laser vaporization of the prostate. Eur Urol 55:679–685PubMedCrossRef
12.
go back to reference Hermanns T, Strebel D, Hefermehl et al (2011) Lithium triborate laser vaporization of the prostate using the 120 W, high performance system laser: high performance all the way? J Urol 185:2241–2247PubMedCrossRef Hermanns T, Strebel D, Hefermehl et al (2011) Lithium triborate laser vaporization of the prostate using the 120 W, high performance system laser: high performance all the way? J Urol 185:2241–2247PubMedCrossRef
13.
go back to reference Heinrich E, Wendt-Nordahl G, Honek P et al (2010) 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol 24:75–79PubMedCrossRef Heinrich E, Wendt-Nordahl G, Honek P et al (2010) 120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol 24:75–79PubMedCrossRef
14.
go back to reference Bachmann A, Muir G, Collins E et al (2012) 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy and perioperative outcome after 201 procedures. Eur Urol 61:600–607PubMedCrossRef Bachmann A, Muir G, Collins E et al (2012) 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy and perioperative outcome after 201 procedures. Eur Urol 61:600–607PubMedCrossRef
Metadata
Title
The 532-nm 180-W (GreenLight®) laser vaporization of the prostate for the treatment of lower urinary tract symptoms: how durable is the new side-fire fiber with integrated cooling system?
Authors
Claus Brunken
Maximilian Munsch
Stephan Tauber
Rainer Schmidt
Christian Seitz
Publication date
01-05-2014
Publisher
Springer London
Published in
Lasers in Medical Science / Issue 3/2014
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-013-1320-7

Other articles of this Issue 3/2014

Lasers in Medical Science 3/2014 Go to the issue